Description
1. Product Overview
Difenoconazole TC is a high-purity, broad-spectrum triazole fungicide technical material, engineered for systemic crop protection against Ascomycetes, Basidiomycetes, and Deuteromycetes pathogens. Its primary industrial application is as the active pharmaceutical ingredient (AI) in formulated fungicides for high-value row crops, fruits, vegetables, and cereals. The key value proposition lies in its exceptional residual activity, rainfastness, and synergistic potential with other modes of action—making it a strategic asset for agrochemical manufacturers seeking to combat resistant fungal strains while maximizing yield protection per unit of applied AI.
2. Key Specifications & Technical Characteristics
-
Chemical composition: Difenoconazole (CAS No. 119446-68-3); empirical formula C₁₉H₁₇Cl₂N₃O₃
-
Purity level: ≥ 95% min. (typical 97% – 98% by HPLC)
-
Physical form: Off-white to light brown crystalline powder
-
Particle size: 98% passing through 325 mesh (≤ 44 µm) for optimal suspension in SC/WG formulations
-
Bulk density: 0.45 – 0.65 g/cm³ (untapped)
-
Melting point: 76 – 82 °C
-
Moisture content: ≤ 0.5%
-
Packaging options:
-
25 kg net kraft paper bag with PE liner
-
200 kg net fiber drum
-
500 kg net flexible intermediate bulk container (FIBC)
-
Custom bulk bags (1,000 kg) on request
-
-
Shelf life: 36 months in original unopened packaging under dry, ambient conditions (≤ 30 °C)
3. Core Industrial Applications
-
Primary industries:
-
Agrochemical formulation manufacturing (SC, EC, WG, FS, and CS formulations)
-
Seed treatment concentrate production
-
Export/import distributors for regulatory-approved territories
-
-
Specific operational use cases:
-
Cereals: Control of Septoria tritici, Puccinia spp., and Fusarium head blight
-
Fruit & vegetables: Powdery mildew on grapes, apples, cucurbits; Alternaria on potatoes and tomatoes
-
Oilseeds & legumes: Cercospora leaf spot on peanuts; Asian soybean rust
-
Seed treatment: Suppression of seed-borne smuts and bunt in wheat and barley
-
-
Performance advantages over alternatives:
-
Longer residual protection (14–21 days) vs. azoxystrobin or mancozeb
-
Two-way systemic movement (xylem + translaminar) enabling coverage of untreated tissue
-
Strong anti-sporulant activity reducing secondary infection cycles
-
Lower dose requirement (60–125 g AI/ha vs. 200–400 g for older triazoles) → cost per hectare advantage for formulators
-
4. Competitive Advantages
-
Quality consistency: ISO 9001:2015 certified production; each batch tested for purity, impurity profile (including related triazole alcohols ≤ 0.3%), and particle size distribution. Certificate of Analysis (CoA) provided per shipment.
-
Supply reliability: Dual-sourcing of key intermediates; 5,000 MT annual production capacity; 12-month rolling forecast commitment available for strategic accounts.
-
Logistics capability: Warehousing in major origin ports (Shanghai, Rotterdam, Houston) with 24-hour dispatch for LCL/FCL orders. Dangerous goods (Class 9, UN 3077) documentation ready.
-
Price competitiveness: Tiered pricing based on volume bands (20 MT, 100 MT, 500 MT+), benchmarked against Chinese and Indian export prices with weekly updates.
-
Sustainability & compliance: Meets EU 1107/2009 impurity limits; REACH-ready documentation; low VOC content in TC form; zero use of banned solvents in production.
-
Technical support: Formulation guidance (WG dispersibility tests, SC rheology optimization), tank-mix compatibility matrix, and regulatory dossier support (5-batch analysis, acute toxicity data).
5. Commercial & Supply Information
-
Minimum Order Quantity (MOQ): BULK 20 MT (one 20-foot container equivalent)
-
Loading capacity:
-
20-foot GP container: 20 MT net (80 × 25 kg bags on pallets)
-
40-foot HC container: 26 MT net (with pallet optimization)
-
-
Lead time: 15–21 days after advance payment or LC confirmation
-
Payment terms: T/T (30% deposit, 70% against BL copy) or irrevocable LC at sight
-
Incoterms preferred: CIF major global port, FOB loading port, or CFR








Reviews
There are no reviews yet.